Rule 2.9 Announcement

Summary by AI BETAClose X

Greencore Group PLC announced that as of September 2, 2025, its issued share capital consists of 442,448,158 ordinary shares with a nominal value of £0.01 each, alongside 1 special rights preference share valued at €1.26. The company does not hold any ordinary shares in treasury. The ISIN for Greencore's ordinary shares is IE0003864109. Greencore also has a sponsored American Depositary Receipts (ADR) program, where one ADR represents four ordinary shares; these ADRs trade over-the-counter in the US under the symbol GNCGY, with CUSIP number 394181101 and ISIN US3941811016.

Disclaimer*

Greencore Group PLC
03 September 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

 

3 September 2025

Greencore Group plc ("Greencore")

Rule 2.9 Announcement

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Greencore confirms that as at close of business on 2 September 2025 its issued share capital consisted of 442,448,158 ordinary shares of £0.01 each and 1 special rights preference share of €1.26. Greencore does not hold any ordinary shares in treasury. The International Securities Identification Number (the "ISIN") for Greencore's ordinary shares is IE0003864109.

Greencore has a sponsored American Depositary Receipts ("ADR") programme for which Bank of New York Mellon acts as the sponsored depositary bank. One ADR represents four ordinary shares of Greencore. The ADRs trade on the US over-the-counter market under the symbol GNCGY. The CUSIP number is 394181101 and the ISIN is US3941811016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings